Ditchcarbon
  • Customers
  1. Organizations
  2. Adallen Pharma Limited
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated 9 days ago

Adallen Pharma Limited

Company website

Adallen Pharma Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2015, the company has rapidly established itself in key operational regions across Europe and beyond, focusing on advanced drug formulations and delivery systems. With a commitment to quality and efficacy, Adallen Pharma offers a range of core products, including prescription medications and over-the-counter solutions that address various health conditions. Their unique approach to research and development has led to several notable achievements, positioning them as a trusted name in the market. As they continue to expand their portfolio, Adallen Pharma remains dedicated to improving patient outcomes through cutting-edge pharmaceutical advancements.

DitchCarbon Score

How does Adallen Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Adallen Pharma Limited's score of 29 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

54%

Let us know if this data was useful to you

Adallen Pharma Limited's reported carbon emissions

In 2023, Adallen Pharma Limited reported total carbon emissions of approximately 263,000 kg CO2e. This figure includes 600 kg CO2e from Scope 1 emissions, primarily from mobile combustion, and 5,000 kg CO2e from Scope 2 emissions, mainly from purchased electricity (2,690 kg CO2e). The majority of their emissions, about 54,000 kg CO2e, fall under Scope 3, which encompasses various activities such as employee commuting (1,400 kg CO2e) and purchased goods and services (231,000 kg CO2e). Despite the significant emissions reported, Adallen Pharma Limited has not established specific reduction targets or initiatives, nor do they participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The absence of formal commitments suggests a need for enhanced climate action strategies within the organisation. All emissions data is directly reported by Adallen Pharma Limited, with no cascaded data from parent or related organisations. The company is headquartered in Great Britain and is positioned within the pharmaceutical industry, which is increasingly scrutinised for its environmental impact.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
-
Scope 2
5,000
Scope 3
54,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adallen Pharma Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Adallen Pharma Limited is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adallen Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Tanner Pharma

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

West Lodge Capital Limited

GB
•
Real estate services (70)
Updated 13 days ago

Durbin PLC

GB
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Caligor Coghlan Pharma Services

US
•
Other business services (74)
Updated 13 days ago

Myonex, LLC

US
•
Health and social work services (85)
Updated 13 days ago

Alium Medical Ltd

GB
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy